| MCF conserved sequences [48] |
Px[D/E]xx[K/R]x[R/K]-20-30 aa-[D/E]Gxxxx[W/Y/F]-[K/R]G |
| Inter-helical association motif [46] |
GxxxG |
| Proton transport residue [54] |
Asp28
|
Glu34
|
Glu55
|
| Charged residues in chloride-binding region [55] |
Asp35, Lys38, Arg88, Asp138, Lys141, Lys239 and Asp236
|
Asp41, Lys44, Arg97, Asp149, Lys152, Lys253 and Asp250
|
Asp60, Lys66, Arg113, Asp163, Lys166, Lys260 and Asp257
|
| PN-binding residues [9] |
Arg88, Arg185, Arg279
|
Arg97, Arg199, Arg299
|
Arg113, Arg206, Arg305
|
| Unique biochemical/biophysical properties |
|
UCP2 |
UCP4 |
UCP5 |
| Expression profile |
Expression in various tissues and organs (brain, muscle, liver, heart, kidney, pancreas) |
Primarily expressed in the brain and the CNS (neurons, astrocytes, Purkinje cells) |
Primarily expressed in the brain and to a lesser extent in testis, uterus, kidney, lung, stomach |
| Sequence identity to UCP1 |
59% |
34% |
30% |
| Proton transport rate (μmol·min−1·mg·protein−1) |
∼2–5 (strongest activator: AA) |
∼1–4 (strongest activator: OA) |
∼2–6 (strongest activator: OA) |
| Chloride transport rate (μmol·min−1·mg·protein−1) |
∼1 |
∼0.5 |
∼0.5 |
| Interaction with CL [11] |
CL induced higher UCP2-mediated H+ flux |
CL had no effect on UCP4-mediated H+ flux |
CL induced higher UCP5-mediated H+ flux |